Search

Your search keyword '"Ostrowski Mario"' showing total 666 results

Search Constraints

Start Over You searched for: Author "Ostrowski Mario" Remove constraint Author: "Ostrowski Mario"
666 results on '"Ostrowski Mario"'

Search Results

3. Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method Study

6. Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity

7. Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

8. T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers

9. Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV

10. Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)

11. Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.

12. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

13. mRNA Vaccine-Induced SARS-CoV-2 Spike-Specific IFN-γ and IL-2 T-cell Responses are Predictive of Serological Neutralization and are Transiently Enhanced by Pre-Existing Cross-Reactive Immunity

14. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

16. Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

17. A bivalent COVID-19 mRNA vaccine, PTX-COVID19-M1.2, elicited broad immune responses and protected animals from SARS-CoV-2 Omicron subvariants infection

18. Longitudinal Analysis of Mpox Virus DNA Detectability From Multiple Specimen Types During Acute Illness: A Cohort Study

19. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses

20. T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response

21. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

22. Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes

23. A single-cell transposable element atlas of human cell identity

24. A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies

25. Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

26. HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

27. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

28. Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2

29. Mechanism of Hard-Nanomaterial Clearance by the Liver *

30. Soluble T Cell Immunoglobulin Mucin Domain 3 Is Shed from CD8+ T Cells by the Sheddase ADAM10, Is Increased in Plasma during Untreated HIV Infection, and Correlates with HIV Disease Progression

31. Tim-3

32. Expansion of Dysfunctional Tim-3–Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques

33. Comparison of Omicron Breakthrough Infection Versus Monovalent SARS-CoV-2 Intramuscular Booster Reveals Differences in Mucosal and Systemic Humoral Immunity

34. Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)–Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women

35. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation

36. T Cells Target APOBEC3 Proteins in Human Immunodeficiency Virus Type 1-Infected Humans and Simian Immunodeficiency Virus-Infected Indian Rhesus Macaques

37. Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods

39. Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2

40. Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV

41. Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]

42. T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection

46. Erratum for Lin et al., “Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity”

48. A second update on mapping the human genetic architecture of COVID-19

50. Longitudinal Analysis of Mpox Virus DNA Detectability from Multiple Anatomic Compartments During Acute Illness: A Cohort Study

Catalog

Books, media, physical & digital resources